Resource Centers
News
- FDA Approves Glycopyrrolate Oral Solution for Chronic Severe Drooling
- New UK Cancer Drugs Fund Moved Forward, As Report Shows UK Lags Behind in Cancer Drug Use
- Aggressive Glucose Control in Patients With Diabetes and Kidney Disease Not Associated With Improved Survival
- Alert Exposure to Estradiol Transdermal Spray Risky for Children and Pets, FDA Says
Articles
-
The SPIRAL Study: Switching to a Raltegravir-Based Regimen
-
CDC Commentary: Personal Genomic Testing: Information for Healthcare Providers
-
Neutralizing Antibody to HIV: Exciting New Research
-
New Research on the Timing of Vaccines and Neurodevelopmental Outcomes
-
Not the Threat You Expect on the Florida Beaches
-
Is Clopidogrel Cessation Before Colonoscopy Unnecessary?
-
New Treasure From Old Trials for Seniors and Obese Patients
-
What's The Evidence for the Link Between ARBs and Cancer? Ileana Piña Talks With Ilke Sipahi
-
A Social Responsibility to Get Vaccinated?
-
CDC Expert Commentary: Prescribing the Correct Antibiotic for Rocky Mountain Spotted Fever Can Be Lifesaving
-
Should We Continue Insulin Secretagogues When Starting Insulin for Type 2 Diabetes?
-
A Promising New Combo for a Rare Uterine Cancer
Commentary and Interviews
POLL
A new study recently published in Health Affairs shows that diabetic and/or hypertensive patients who emailed their physicians with questions or information were more likely to lower their blood pressure and be screened for complications related to their disease. How often do you communicate with your patients via email?
Advisory Board
Site Editorial Director
Site Editor
Also of Interest
- Alert Exposure to Estradiol Transdermal Spray Risky for Children and Pets, FDA Says
- Aggressive Glucose Control in Patients With Diabetes and Kidney Disease Not Associated With Improved Survival